Solar Pharma recollects 13,000 bottles of chewable Cetirizine in US


New Delhi: The US arm of home drug main Solar Pharma is recalling over 13,000 bottles of antihistamine, Kids’s Cetirizine Hydrochloride chewable tablets, from the American marketplace for failed specs.

Solar Pharmaceutical Industries Inc is recalling 13,200 bottles of the tablets within the power of 5 mg made at Halol plant, US FDA mentioned in its newest Enforcement Report. The continued class III recall is nationwide within the USA and Puerto Rico, report added.

The explanation for the recall is “failed pill/capsule specs: out of specification outcomes for elevated pill hardness”, United States Meals and Drug Administration (USFDA) mentioned.

As per the US well being regulator, a category III recall is initiated in a state of affairs, “wherein use of or publicity to a violative product will not be prone to trigger hostile well being penalties”.

Catch all of the Company information and Updates on Reside Mint.
Obtain The Mint Information App to get Every day Market Updates & Reside Enterprise Information.

Much less

Subscribe to Mint Newsletters

* Enter a legitimate electronic mail

* Thanks for subscribing to our e-newsletter.


Supply hyperlink